Adocia
ADOC.PA$91M
Micro CapEuronext ParisBiotechnology🇫🇷Europe77 employees
Drugs in Pipeline
6
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
ADOC.PA News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
BioChaperone PDGF-BB
Diabetic Foot Ulcer
M1 Pram P037
Type 1 Diabetes Mellitus
BioChaperone insulin lispro 0.2U/Kg
Diabetes Mellitus Type 1
BioChaperone human insulin
Diabetes Mellitus Type 1
ADO09 formulation
Type 1 Diabetes Mellitus
BioChaperone Human Insulin (HinsBet®)
Type 1 Diabetes Mellitus
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
BioChaperone PDGF-BB | Phase 3 | Diabetic Foot Ulcer | - | - |
M1 Pram P037 | Phase 2 | Type 1 Diabetes Mellitus | - | - |
BioChaperone insulin lispro 0.2U/Kg | Phase 2 | Diabetes Mellitus Type 1 | - | - |
BioChaperone human insulin | Phase 2 | Diabetes Mellitus Type 1 | - | - |
ADO09 formulation | Phase 2 | Type 1 Diabetes Mellitus | - | - |
BioChaperone Human Insulin (HinsBet®) | Phase 2 | Type 1 Diabetes Mellitus | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply